These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9554189

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Papillary thyroid carcinoma associated with parathyroid adenoma detected by pertechnetate-MIBI subtraction scintigraphy.
    Rubello D, Toniato A, Pelizzo MR, Casara D.
    Clin Nucl Med; 2000 Nov; 25(11):898-900. PubMed ID: 11079587
    [Abstract] [Full Text] [Related]

  • 3. [Use of SPECT with (99m)Tc-Sestamibi in a patient affected by laryngeal carcinoma and parathyroid adenoma].
    Giordano A, Galli J, Corina L, Samanes Gajate AM, D'Andrea G, Almadori G.
    Rev Esp Med Nucl; 2000 Jun; 19(3):211-4. PubMed ID: 11062085
    [Abstract] [Full Text] [Related]

  • 4. Primary hyperparathyroidism: higher success rate of first surgery after preoperative Tc-99m sestamibi-I-123 subtraction scanning.
    Hindié E, Mellière D, Perlemuter L, Jeanguillaume C, Galle P.
    Radiology; 1997 Jul; 204(1):221-8. PubMed ID: 9205251
    [Abstract] [Full Text] [Related]

  • 5. A false-positive localization of a parathyroid adenoma with technetium Tc 99m sestamibi scan secondary to a thyroid follicular carcinoma.
    Koss WG, Brown MR, Balfour JF.
    Arch Surg; 1996 Feb; 131(2):216-7. PubMed ID: 8611082
    [Abstract] [Full Text] [Related]

  • 6. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique.
    Rubello D, Saladini G, Casara D, Borsato N, Toniato A, Piotto A, Bernante P, Pelizzo MR.
    Clin Nucl Med; 2000 Jul; 25(7):527-31. PubMed ID: 10885694
    [Abstract] [Full Text] [Related]

  • 7. Intraoperative localization of parathyroid adenoma using 99Mtechnetium sestamibi.
    Burns C, Oppenheimer M, Wheeler K.
    S D J Med; 1994 Jun; 47(6):202-4. PubMed ID: 8023130
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tc-99m sestamibi for detection of parathyroid adenoma. Comparison of single and dual tracer imaging.
    Rossitch JC, Cowan RJ, Ellis MB, Griffith RF.
    Clin Nucl Med; 1995 Mar; 20(3):220-1. PubMed ID: 7750214
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
    Chen CC, Holder LE, Scovill WA, Tehan AM, Gann DS.
    J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
    [Abstract] [Full Text] [Related]

  • 14. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
    Leslie WD, Dupont JO, Bybel B, Riese KT.
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
    [Abstract] [Full Text] [Related]

  • 15. Fetal adenoma of the thyroid. A common source for false-positive thallium-201/technetium-99m pertechnetate subtraction parathyroid scintigraphy.
    Krubsack AJ.
    Clin Nucl Med; 1987 Jul; 12(7):539-42. PubMed ID: 2886243
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.